THERAPLAS

Trademark usage description

development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; biolo Read More

Classification Information

Class [042]
Development of platform technology, namely, cancer immunotherapy, infectious disease, and gene therapy platforms for manufacturing therapeutics; biological and biotechnology research; research and development in the pharmaceutical and biotechnology fields; scientific research and development with regard to the manufacture of pharmaceutical preparations; chemical and biological analysis; development of pharmaceutical preparations for treating cancer; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific and technological research in the fields of genetics, immunotherapy, vaccination, and oncology.

Classification kind code

Mark Details

Serial Number

2287944

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 26 on 30^th Jan 2025	Approved
Submitted for opposition 27 on 30^th Jan 2025	Approval Notice Sent
Submitted for opposition 22 on 22^nd Jan 2025	Search Recorded
Submitted for opposition 256 on 19^th Aug 2024	Notification of Possible Opposition Sent
Submitted for opposition 257 on 19^th Oct 2023	Designation Notification - Madrid Protocol
Submitted for opposition 31 on 18^th Oct 2023	Formalized
Submitted for opposition 1 on 18^th Oct 2023	Created
Submitted for opposition 228 on 13^th Sept 2023	International Registration
Submitted for opposition 30 on 13^th Sept 2023	Filed